NetworkNewsBreaks

WednesdayJun 18, 2025 1:51 pm

NetworkNewsBreaks – Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)

Aegis Capital, acting as sole book-running manager, today announced the successful closing of a $4.3 million underwritten public offering for Stardust Power Inc. (NASDAQ: SDST), an American developer of battery-grade lithium products. The offering included 21,500,000 shares of common stock at a public offering price of $0.20 per share. Stardust Power has also granted Aegis a 45-day option to purchase up to an additional 3,225,000 shares to cover over-allotments, which could bring total gross proceeds to approximately $4.9 million. Proceeds from the offering will fund the completion of the Definitive Feasibility Study (DFS/FEL-3) for the Company’s proposed lithium processing facility…

Continue Reading

WednesdayJun 18, 2025 11:39 am

NetworkNewsBreaks – Psyence Biomedical Ltd. (NASDAQ: PBM) to Present at Psychedelic Science 2025

Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, was selected as a featured speaker at Psychedelic Science 2025 (“PS2025”) – the world's largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture. Hosted by the Multidisciplinary Association for Psychedelic Studies (“MAPS”), the highly anticipated conference is taking place June 16-20, 2025, in Denver, Colorado. Psyence BioMed will present on business ethics in a panel session, “We are the Guardrails: Profit with Purpose.” In the role of Chief of Global Impact for Psyence Biomed, the first Nasdaq-listed biopharma with a focus on developing…

Continue Reading

WednesdayJun 18, 2025 10:45 am

NetworkNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia

Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS’s first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under ten minutes, enabling rapid safety decisions without disrupting field operations. INBS continues to expand its reach into safety-critical industries, with its scalable, sweat-based drug testing now in use by over 450 organizations across 24 countries.…

Continue Reading

WednesdayJun 18, 2025 9:44 am

NetworkNewsBreaks – Red Cat Holdings Inc. (NASDAQ: RCAT) Announces $46.75M Registered Direct 

Red Cat Holdings (NASDAQ: RCAT), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, has announced its entry into securities purchase agreements with certain institutional investors for the purchase and sale of 6,448,276 shares of common stock, pursuant to a registered direct offering. The company anticipates gross proceeds of approximately $46.75 million from the offering, which, subject to the satisfaction of customary conditions, is expected to close on or about June 18, 2025. Red Cat intends to use net proceeds for general corporate and working capital purposes, including but not limited to operating expenditures…

Continue Reading

WednesdayJun 18, 2025 9:30 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology 

HeartBeam (NASDAQ: BEAT), announced the issuance of two new U.S. patents that strengthen its intellectual property portfolio and support the company’s expansion in remote cardiac diagnostics. The new patents protect core technologies behind HeartBeam’s compact, cable-free 3D ECG device and its rhythm analysis algorithm capable of identifying arrhythmias through continuous signal input.  The 3D ECG device, which uses chest and finger electrodes to collect high-fidelity signals in three non-coplanar directions, is designed for on-demand symptom recording and 12-lead ECG synthesis. Its software is currently under FDA review, backed by data from the VALID-ECG pivotal study. The rhythm algorithm works across…

Continue Reading

WednesdayJun 18, 2025 9:20 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the successful commercial manufacturing process scale-up of its lead product, Aversa™ Fentanyl, in collaboration with Kindeva, a global CDMO specializing in drug-device combinations. Aversa Fentanyl integrates Nutriband’s AVERSA™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch and is produced at Kindeva’s U.S.-based transdermal facility. The next step involves producing clinical supplies and submitting an Investigational New Drug application to begin a human abuse liability study. Nutriband projects Aversa Fentanyl, which aims to be the world’s first abuse-deterrent opioid patch, could achieve peak U.S. sales between $80 million and $200 million,…

Continue Reading

WednesdayJun 18, 2025 9:10 am

NetworkNewsBreaks – GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced it has finalized a Share Exchange Agreement to acquire 100% of Charter House Financial AU, with the transaction set to close by July 13, 2025. The acquisition marks a shift in GivBux's strategic focus toward gold-backed financial services, leveraging Charter House’s asset-backed infrastructure and global networks. The companies plan to integrate operations and jointly develop offerings that fuse precious metals with digital payments through the GivBux app. Charter House founder Anthony Capazze, a 25-year veteran in gold markets and finance, projected potential revenue of up to $200…

Continue Reading

WednesdayJun 18, 2025 9:00 am

NetworkNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf brand, announced that PGA TOUR Champions star Miguel Ángel Jiménez has officially joined the company and will play its Newton Fast Motion shaft, which he used to win the Principal Charity Classic. Jiménez’s playoff win in Iowa marked his 16th PGA TOUR Champions title and the second Tour victory for Newton’s Motion shaft line. The Fast Motion shaft, launched in April 2025, features advanced carbon fiber construction and proprietary performance technologies aimed at delivering speed, control, and consistency for golfers with moderate swing speeds. The win further validates Newton’s impact across professional…

Continue Reading

TuesdayJun 17, 2025 1:19 pm

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) to Upgrade to OTCID Tier on July 1, Signaling Stronger Market Position

BluSky AI (OTC: BSAI) announced it will transition from the OTC Pink Sheets to the OTCID tier effective July 1, 2025, reflecting its enhanced reporting, compliance, and transparency standards. The move marks a milestone in the company’s strategic growth, following recent achievements including modular AI datacenter expansion, new infrastructure partnerships, a GPU-as-a-Service launch, and improved financial governance. CEO Trent D’Ambrosio stated the upgrade underscores BluSky AI’s commitment to investor confidence and long-term value creation as it seeks broader market visibility and access to capital. To view the full press release, visit https://nnw.fm/u1kjG About BluSky AI Inc.  Blusky AI, headquartered in…

Continue Reading

TuesdayJun 17, 2025 12:55 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project 

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced a non-brokered private placement of units priced at $0.73 each, targeting gross proceeds of up to $3.285 million. Each unit comprises one common share and one share purchase warrant, exercisable at $0.91 for 18 months. The initial closing is scheduled for June 20, 2025, with additional tranches possible. Proceeds will support mill circuit construction, final mobilization at the Montauban Gold-Silver Project, and general working capital. The placement remains subject to Canadian Securities Exchange approval. To view the full press release, visit https://nnw.fm/VbM54 About ESGold Corp. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully…

Continue Reading